Humana (NYSE:HUM) Price Target Raised to $290.00

Humana (NYSE:HUM) had its target price raised by Truist Financial from $260.00 to $290.00 in a research report report published on Monday morning,Benzinga reports. Truist Financial currently has a hold rating on the insurance provider’s stock.

Several other research analysts have also commented on the stock. Leerink Partnrs lowered shares of Humana from a “strong-buy” rating to a “hold” rating in a report on Wednesday, October 2nd. Jefferies Financial Group lowered shares of Humana from a “buy” rating to a “hold” rating and lowered their price objective for the stock from $519.00 to $253.00 in a report on Monday, October 7th. Stephens reiterated an “equal weight” rating and set a $250.00 target price on shares of Humana in a report on Wednesday, October 9th. Morgan Stanley increased their target price on Humana from $288.00 to $301.00 and gave the stock an “equal weight” rating in a research report on Tuesday, December 17th. Finally, UBS Group reduced their price target on Humana from $380.00 to $250.00 and set a “neutral” rating on the stock in a research note on Friday, October 4th. Twenty analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $302.00.

Humana Trading Up 0.4 %

Shares of HUM opened at $268.22 on Monday. The stock has a market capitalization of $32.30 billion, a P/E ratio of 23.76, a PEG ratio of 2.12 and a beta of 0.55. Humana has a twelve month low of $213.31 and a twelve month high of $462.08. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67. The firm has a fifty day simple moving average of $272.86 and a two-hundred day simple moving average of $311.86.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, topping analysts’ consensus estimates of $3.48 by $0.68. The company had revenue of $29.30 billion during the quarter, compared to analyst estimates of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. On average, research analysts anticipate that Humana will post 16.14 EPS for the current year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.32%. The ex-dividend date is Tuesday, December 31st. Humana’s payout ratio is currently 31.36%.

Insider Buying and Selling

In other news, insider Timothy S. Huval sold 3,703 shares of the firm’s stock in a transaction dated Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the sale, the insider now owns 8,181 shares of the company’s stock, valued at $2,096,463.06. This trade represents a 31.16 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.32% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. PDT Partners LLC raised its stake in Humana by 190.0% during the 3rd quarter. PDT Partners LLC now owns 4,060 shares of the insurance provider’s stock valued at $1,286,000 after buying an additional 2,660 shares during the last quarter. Ontario Teachers Pension Plan Board grew its holdings in shares of Humana by 6.5% in the third quarter. Ontario Teachers Pension Plan Board now owns 1,173,535 shares of the insurance provider’s stock worth $371,705,000 after acquiring an additional 71,910 shares during the period. Swedbank AB increased its position in Humana by 3.0% during the third quarter. Swedbank AB now owns 105,976 shares of the insurance provider’s stock valued at $33,567,000 after acquiring an additional 3,085 shares during the last quarter. Wilmington Savings Fund Society FSB bought a new position in Humana in the third quarter valued at about $948,000. Finally, Heritage Oak Wealth Advisors LLC bought a new position in Humana in the second quarter valued at about $3,456,000. Institutional investors own 92.38% of the company’s stock.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.